Single-cell profile reveals the landscape of cardiac immunity and identifies a cardio-protective Ym-1hi neutrophil

Myocardial ischemia-reperfusion injury (MIRI) is a major hindrance to the success of cardiac reperfusion therapy. Immune response mediates the pathophysiological process of MIRI, implying that regulating immune responses within a certain time window may be an effective strategy for treating MIRI.

Facebook Comments